Central to diabetes pathology is the destruction or dysfunction of insulin‐producing pancreatic β cells, prompting exploration into regenerative solutions such as reprogramming human‐induced pluripotent stem cells (hiPSCs), which are self‐renewing resources capable of differentiating into functional β cells [260]. This evidence concerns the gene INS and diabetes mellitus.